Jacob Margolin Resignation Letter as CEO of Clinigence Holdings, Inc.
Jacob “Kobi” Margolin formally resigns as Chief Executive Officer of Clinigence Holdings, Inc., effective July 12, 2020. He expresses gratitude to the board and Chairman Dr. Warren Hosseinion, and announces Dr. Larry Schimmel as his successor. Margolin will remain involved with the company as a member of the board of directors, continuing to provide guidance and support.
July 12, 2020
Dear Clinigence Holdings, Inc. Board of Directors
As per our agreement today, please accept this letter as formal notification that I am resigning from my position as Chief Executive Officer of Clinigence Holdings, Inc. (the “Company”) effective today.
After more than a decade of taking Clinigence from a sketch of an idea on a pizza box to a public company leading the healthcare market through the turbulent waters of resource and value optimization, it is time for me to start a new chapter.
I am grateful to our Chairman, Dr. Warren Hosseinion for helping us navigate our way to the public markets over the past two years. I have learned a great deal from him and from each and every one of you.
I trust that you, along with my esteemed colleague, co-founder of Qualmetrix, and successor as CEO – Dr. Larry Schimmel - will continue leading Clinigence into more growth and success in the coming years.
You may be losing me as CEO, but I will continue to offer guidance and assistance to you as a member of the board of directors.
Sincerely,
Jacob “Kobi” Margolin
